What you need to know about Joe Manchins daughter

According to newly unsealed court documents, Heather Bresch, the former president and CEO of the drugmaker Mylan — and Sen. Joe Manchin’s daughter — colluded directly with the CEO of Pfizer to keep prices of Mylan’s EpiPens artificially high.

According to newly unsealed court documents acquired by The Intercept, Sen. Joe Manchin’s daughter, a former pharmaceutical CEO, collaborated directly with the CEO of Pfizer to keep EpiPen prices artificially high.

Heather Bresch — then the CEO of Mylan, which holds a patent for EpiPens — orchestrated a scheme in which Pfizer would divest from its EpiPen competitor, giving Mylan a virtual monopoly on the lifesaving medication. In just a few short years, the price for two EpiPens skyrocketed from $100 to $600.

As Manchin threatens to tank President Joe Biden’s $3.5 trillion infrastructure package, which would threaten pharmaceutical profits by allowing Medicare... to negotiate for lower prescription drug prices, The Intercept is continuing to investigate the Manchin family’s questionable business dealings.

These important revelations are being brought to light thanks to The Intercept’s investigative journalists. Will you chip in today and help our nonprofit newsroom uncover how corporate greed and right-wing Democrats are threatening to block the Biden agenda?

If you’ve saved your payment information with ActBlue Express, your donation will go through immediately:

DONATE $15 →

DONATE $25 →

DONATE $50 →

DONATE $100 →


This isn’t the first time that Joe Manchin and his wife, Gayle Manchin, have used their political influence to increase the profitability of their daughter’s company. As the head of the National Association of State Boards of Education, Bresch’s mother lobbied states to require schools to stock epinephrine.

And a new expose by The Intercept and Type Investigations reveals that it’s not just Manchin’s daughter who has been involved in shady business dealings.

After entering politics, Joe Manchin left his son in charge of a series of coal companies the senior Manchin had founded. While the senator is no longer involved in the day-to-day operations of the companies, he has personally grossed more than $4.5 million from those firms and retains millions more in stock options, according to financial disclosures.

These business dealings are under new scrutiny after Manchin came out against several climate provisions in the Democrats’ $3.5 trillion reconciliation package — provisions that could jeopardize the Manchin family fossil fuel fortune if they were to become law.

The Intercept has been a leading voice in exposing Manchin’s conflicts of interest that pit action to tackle the climate crisis against his family’s wealth. And these newly unsealed documents provide a startling window into the ways in which corporate pharma executives manipulate markets and price-gouge patients in order to line their pockets. But these investigations require painstaking reporting, sifting through government and financial documents, and more.

Our newsroom rejects corporate advertising on our website and refuses to put our journalism behind a paywall. Instead, we rely on readers like you to help power our work. Will you chip in today to help us dig deep, expose corruption, and hold the powerful to account?


Thank you, The Intercept team

First Look Institute is a 501(c)(3) charitable organization (tax ID number 80-0951255).

The Intercept’s mailing address is:
First Look Institute
P.O. Box 27442
Washington, DC 20038

The Intercept is an award-winning nonprofit news organization dedicated to holding the powerful accountable through fearless, adversarial journalism. Our in-depth investigations and unflinching analysis focus on surveillance, war, corruption, the environment, technology, criminal justice, the media and more. Email is an important way for us to communicate with The Intercept’s readers, but if you’d like to stop hearing from us, click here to r0 from all communications. Protecting freedom of the press has never been more important. Contribute now to support our independent journalism.

Login Form